Complications of Epidural Injections

Published on 27/02/2015 by admin

Filed under Anesthesiology

Last modified 27/02/2015

Print this page

This article have been viewed 2431 times

Chapter 13 Complications of Epidural Injections

Matthew T. Ranson

Chapter Overview

Chapter Synopsis: Epidural steroid injection (ESI) for the treatment of chronic pain requires physician expertise not only in the injection procedure itself but also in the technique of using fluoroscopic guidance. ESI carries risks associated with the injection as well as with the injected steroid. The lowest possible steroid dose should always be used to avoid drug effects. One possible complication of ESI is suppression of the hypothalamic–pituitary–adrenal axis. Transforaminal injections to the cervical spine should be carefully considered because they carry a greater risk of catastrophic complications.

Important Points:

Epidural injections for the treatment of chronic pain should only be performed by well-trained physicians under fluoroscopic guidance.

American Society of Regional Anesthesia guidelines should be consulted before neuraxial interventions on patients receiving anticoagulants. However, it is important to recognize these guidelines do not specifically address interventional pain procedures.

The lowest dose of steroid that could be expected to have a clinical response should be used in the epidural space.

No prospective data have shown that a large dose of steroid is superior to low doses.

Cervical transforaminal injections should be approached with great caution and should only be performed when clinical issues suggest a specific nerve involved in the pain pattern.

Introduction

Epidural steroid injections (ESIs) have been associated with a myriad of complications and side effects. Although the overall incidence of complications from ESIs appears to be low,¹ there are some potentially catastrophic complications that should be considered by all physicians performing these procedures. There are two general categories of complications associated with ESIs: exogenous steroid side effects and complications associated with the actual placement of the needle by the physician performing the procedure. Complications associated with ESIs are discussed in this chapter and are organized into medication-associated complications and those complications that may result from the procedure.

Complications of Steroid Administration

Complications that may result from corticosteroid injections include hyperglycemia, Cushing syndrome, hypertension, deep venous thrombosis (DVT), secondary infections, psychological disorders, lipid accumulation (epidural lipomatosis), osteoporosis, vertebral compression fractures, avascular necrosis of joints, and numerous other endocrine and dermatologic manifestations.² Epidural steroid administration has been demonstrated to adversely affect native cortisol concentrations for up to 30 days from a single injection.³ It is likely that suppression of the hypothalamic–pituitary–adrenal (HPA) axis is variable among individuals, but there is evidence that a series of three epidural injections with 40 mg of triamcinolone may suppress the HPA axis for up to 3 months.² Serious side effects such as steroid myopathy and Cushing syndrome have been reported after a single epidural dose of triamcinolone.⁴ Although the risk of complications from ESIs theoretically should increase with increasing frequency of injections, it appears that total dose of steroids given during a specific time may be more important in determining steroid complications.^5,⁶

Particulate steroids have been under increasing scrutiny because of the theoretical risk of high particulate steroid preparations causing vascular events.

Recommendations for Avoiding Steroid Complications

The total annual dose of steroid should be limited to the smallest efficacious dose. Although there is insufficient evidence to determine the risks of epidural steroid administration, evidence suggests that large annual doses of steroids may lead to serious complications. There is no evidence that large doses of steroids are superior to low doses. Recommendations have been made to limit the amount of annual steroid dose to 3 mg/kg of triamcinolone or equivalent.⁷ See Tables 13-1 and 13-2 for commercially available steroid preparations and their relative potencies.

Table 13-1 Commercially Available Steroids

Steroid	Available Concentrations (mg/mL)	Typical Doses (mg)
Depo-Medrol (methylprednisolone)	40, 80	40–80
Celestone (betamethasone)	6	6–12
Kenalog (triamcinolone)	25, 40	40–80
Decadron (dexamethasone)	4, 8	4–10

Adapted from Deer T, Ranson M, Kappural L, Diwan SA: Guidelines for the proper use of epidural steroid injections for the chronic pain patient, Tech Reg Anesth Pain Manage 13(4):288-295, 2009.

Table 13-2 Relative Potencies of Steroids

Transforaminal ESIs, especially in the cervical spine, have been reported to result in catastrophic complications, including stroke, paralysis, and death.⁸ Although there are more case reports of complications with transforaminal injections in the cervical spine, there are some reports of neurologic injury in the lumbar spine.⁹ Several mechanisms have been proposed for the development of anterior spinal artery syndrome, including mechanical trauma to a radicular artery supplying the anterior or posterior spinal arteries, vasospasm, and embolism resulting from particulate-containing steroids (Figs. 13-1 and 13-2).^10,¹¹ The use of nonparticulate steroids has been suggested to be safer than particulate steroids when performing cervical transforaminal injections.¹² Cervical transforaminal injections should be approached with caution,⁷ and prudent physicians should consider using nonparticulate steroid solutions such as dexamethasone when performing transforaminal epidural injections in the thoracic and upper lumbar spine.